Kewaunee Scientific Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Kewaunee Scientific şu anda temettü ödemiyor.

Anahtar bilgiler

Temettü verimi

1.6%

Geri Alım Getirisi

Toplam Hissedar Getirisi	1.6%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	US$0.760
Ödeme oranı	0%

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Sep 24

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

Sep 17

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Sep 10

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Aug 23

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Jul 11

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Jun 19

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

Dec 18

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

Jul 02

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: KEQU şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: KEQU şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Kewaunee Scientific Piyasaya Karşı Temettü Getirisi

KEQU temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (KEQU)	0%
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.2%
Sektör Ortalaması (Medical Equipment)	1.6%
Analist tahmini (KEQU) (3 yıla kadar)	n/a

Önemli Temettü: KEQU şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, KEQU şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: KEQU US piyasası için dikkate değer bir temettü ödemiyor.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: KEQU herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Kewaunee Scientific Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

The Excitement Around Kewaunee Scientific Corporation's Business Turnaround Is Dying Out

Kewaunee Scientific Corporation (NASDAQ:KEQU) Looks Inexpensive After Falling 25% But Perhaps Not Attractive Enough

With EPS Growth And More, Kewaunee Scientific (NASDAQ:KEQU) Makes An Interesting Case

Kewaunee Scientific Corporation to Report Q1, 2025 Results on Sep 11, 2024

Kewaunee Scientific (NASDAQ:KEQU) Is Doing The Right Things To Multiply Its Share Price

Concerns Surrounding Kewaunee Scientific's (NASDAQ:KEQU) Performance

Kewaunee Scientific Corporation, Annual General Meeting, Aug 28, 2024

Kewaunee Scientific (NASDAQ:KEQU) Has A Pretty Healthy Balance Sheet

Kewaunee Scientific Corporation to Report Q4, 2024 Results on Jun 26, 2024

Investor sentiment improves as stock rises 18%

Vice President of Human Resources recently sold US$107k worth of stock

Insider recently sold US$93k worth of stock

Insider notifies of intention to sell stock

Third quarter 2024 earnings released: EPS: US$0.87 (vs US$0.26 in 3Q 2023)

Kewaunee Scientific Corporation to Report Q3, 2024 Results on Mar 06, 2024

Investor sentiment improves as stock rises 18%

Even With A 26% Surge, Cautious Investors Are Not Rewarding Kewaunee Scientific Corporation's (NASDAQ:KEQU) Performance Completely

President recently sold US$137k worth of stock

President notifies of intention to sell stock

Investor sentiment improves as stock rises 36%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: US$0.94 (vs US$0.086 loss in 2Q 2023)

Kewaunee Scientific Corporation to Report Q2, 2024 Results on Dec 06, 2023

First quarter 2024 earnings released: EPS: US$0.86 (vs US$0.27 loss in 1Q 2023)

Kewaunee Scientific Corporation, Annual General Meeting, Aug 23, 2023

New minor risk - Shareholder dilution

Investors Could Be Concerned With Kewaunee Scientific's (NASDAQ:KEQU) Returns On Capital

President exercised options and sold US$92k worth of stock

New minor risk - Insider selling

Insider recently bought US$657k worth of stock

Kewaunee Scientific (NASDAQ:KEQU) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings released: EPS: US$0.26 (vs US$0.47 loss in 3Q 2022)

Second quarter 2023 earnings released: US$0.086 loss per share (vs US$1.11 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: US$0.27 loss per share (vs US$0.48 loss in 1Q 2022)

Kewaunee Scientific GAAP EPS of -$0.27, revenue of $50.12M

Kewaunee Scientific Corporation, Annual General Meeting, Aug 24, 2022

Full year 2022 earnings released: US$2.20 loss per share (vs US$1.33 loss in FY 2021)

Kewaunee Scientific GAAP EPS of -$0.13, revenue of $49.72M

Insider recently bought US$421k worth of stock

Insufficient new directors

Insufficient new directors

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Kewaunee Scientific Corporation announced delayed 10-Q filing

First quarter 2022 earnings released: US$0.48 loss per share (vs US$0.22 loss in 1Q 2021)

Full year 2021 earnings released: US$1.33 loss per share (vs US$1.70 loss in FY 2020)

Is Kewaunee Scientific (NASDAQ:KEQU) Weighed On By Its Debt Load?

Third quarter 2021 earnings released: EPS US$0.029 (vs US$0.70 loss in 3Q 2020)

Kewaunee Scientific Corporation to Report Q3, 2021 Results on Mar 10, 2021

New 90-day high: US$13.37

New 90-day high: US$12.56

Here's Why Kewaunee Scientific (NASDAQ:KEQU) Can Afford Some Debt

New 90-day high: US$9.79

Second quarter 2021 earnings released: US$0.065 loss per share

Kewaunee Scientific reports Q2 results

New 90-day high: US$9.75

Kewaunee Scientific Corporation to Report Q2, 2021 Results on Dec 09, 2020

New 90-day low: US$8.33

New 90-day low: US$8.72

First quarter earnings released

Kewaunee Scientific Corporation to Report Q1, 2021 Results on Sep 08, 2020

New 90-day high - US$10.25

Kewaunee Scientific Corporation(NasdaqGM:KEQU) dropped from Russell Microcap Growth Index

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin